One of the nation's most renowned pain experts, Dr. Edgar Ross, joins JanOne's Scientific Advisory Board

Rhea-AI Summary

JanOne Inc. (NASDAQ:JAN) announced the addition of Dr. Edgar Ross to its scientific advisory board on June 30, 2020. Dr. Ross, a distinguished pain management specialist and director at Brigham and Women's Hospital, brings over 40 years of experience and has published extensively in the field. His expertise aims to enhance JanOne's mission to develop non-addictive pain relief solutions. CEO Tony Isaac expressed confidence in Dr. Ross’s contributions towards innovative alternatives to opioids as the company advances its phase 2b trials for treatments related to peripheral artery disease.

Positive

• Dr. Edgar Ross's addition to the advisory board enhances JanOne's expertise in pain management.
• Ross's extensive experience and recognition in the field may accelerate the company's R&D initiatives.
• The focus on non-addictive pain solutions aligns with current healthcare trends and needs.

Negative

• None.

LAS VEGAS, June 30, 2020 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs and therapies with non-addictive pain-relieving properties announced today that Edgar Ross, MD will join the company's scientific advisory board. Dr. Ross is the current Director of the Pain Management Center at Brigham and Women's Hospital and associate professor of anesthesia at Harvard Medical School. He brings over 40 years of experience in the medical field and is a highly regarded pain specialist. Among his many accomplishments, Dr. Ross has published over 100 manuscripts on pain management, participated in numerous pain-related clinical trials for some of the world's top pharmaceutical companies, and served as Chairman of Pfizer's medical and academic partnership on pain.

Tony Isaac, CEO of JanOne, commented, "We are honored to have Dr. Ross join our scientific advisory board. His insight and expertise in pain management and pain medicine will be invaluable to our mission to bring non-addictive pain solutions to market."

Dr. Ross has been recognized by the American Pain Society for top quality clinical care in pain management and has been named as a top 1% of physicians in the United States by US News and World Report. Most recently, Dr. Ross was recognized as one of Boston's top doctors in 2020 and marks the fifth time he has received the honor as well as was recently recognized as Castle Connolly's America's top doctors for the fifth year in a row. In addition to serving as chairman of Pfizer's partnership on pain, Dr. Ross also has served as a member of the Blue Cross and Blue Shield Opioid Prescribing Policy Committee.

Dr. Ross stated, "I look forward to working with JanOne's Chief Medical Officer Dr. Amol Soin and Chief Scientific Officer Dr. Tony Giordano as they are both are recognized for their accomplishments in pain management and non-addictive pain medications. I hope my research and clinical experience will accelerate many new and exciting initiatives currently underway at JanOne, most notably to find an alternative to prescription opioids for pain remediation."

Dr. Ross graduated from Wayne State University School of Medicine in 1980 and is board-certified for anesthesiology and pain management with clinical interest in vascular pain.

About JanOne
JanOne is a unique NASDAQ-listed company that is focused on bringing medications to market to treat diseases that cause severe pain in an effort to reduce the need for prescriptions opioids often used to treat disease associated pain. The company is also exploring solutions for non-addictive pain medications. The lead candidate is for treating peripheral artery disease (PAD), a condition that affects over 8.5 million Americans, with plans currently underway for phase 2b trials. JanOne is currently dedicated to funding resources toward innovation, technology, and education for PAD and neuropathic pain. The company continues to operate its legacy businesses, ARCA Recycling and GeoTraq, under their current brand names. ARCA Recycling provides turnkey recycling and replacement services for utilities and other sponsors of energy efficiency programs. GeoTraq engages in the development, design and, ultimately, the company expects, sale of Mobile IoT modules. Please visit www.janone.com for additional information.

Media contact:

Mark Rosenberg
mark@trueparallel.com
919-412-7378

View original content to download multimedia:http://www.prnewswire.com/news-releases/one-of-the-nations-most-renowned-pain-experts-dr-edgar-ross-joins-janones-scientific-advisory-board-301085884.html

SOURCE JanOne

FAQ

Who is Dr. Edgar Ross and what is his role at JanOne?

Dr. Edgar Ross is a renowned pain management specialist who has joined JanOne's scientific advisory board to provide expertise on non-addictive pain solutions.

What is the significance of Dr. Ross joining JanOne's scientific advisory board?

Dr. Ross's extensive experience in pain management is expected to bolster JanOne's research and development efforts in creating alternatives to opioid pain medications.

What is JanOne's current focus in terms of drug development?

JanOne is focused on developing non-addictive treatments for severe pain, with ongoing phase 2b trials targeting peripheral artery disease.

What are the potential impacts of Dr. Ross's expertise on JanOne's initiatives?

Dr. Ross's expertise may expedite new research initiatives and enhance the effectiveness of JanOne's pain management solutions.